Article
Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Anti-cancer drugs - 1 Oct 2017
Steely Andrea M, Willoughby Jamin A, Sundar Shyam N, Aivaliotis Vasiliki I, Firestone Gary L
Abstract excerpt
Androgen receptor (AR) expression and activity is highly linked to the development and progression of prostate cancer and is a target of therapeutic strategies for this disease. We investigated whether the antimalarial drug artemisinin, which is a sesquiterpene lactone isolated from the sweet wormwood plant Artemisia annua, could alter AR expression and responsiveness in cultured human prostate cancer cell lines....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
